mycophenolic-acid and Sleep-Apnea--Obstructive

mycophenolic-acid has been researched along with Sleep-Apnea--Obstructive* in 1 studies

Other Studies

1 other study(ies) available for mycophenolic-acid and Sleep-Apnea--Obstructive

Article	Year
Resolution of severe obstructive sleep apnea after treatment of anti-muscle kinase receptor-positive myasthenia gravis despite 60-pound weight gain. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014, Jul-15, Volume: 10, Issue:7 Obstructive sleep apnea (OSA) in patients with myasthenia gravis (MG) may be caused by reduced pharyngeal dilator muscle activity. We report a patient with anti-muscle kinase receptor MG with severe OSA and hypoventilation that resolved upon successful treatment of MG despite a 60-lb weight gain. Topics: Anti-Inflammatory Agents; Female; Follow-Up Studies; Humans; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Prednisone; Sleep Apnea, Obstructive; Treatment Outcome; Weight Gain	2014

Article

Year

Resolution of severe obstructive sleep apnea after treatment of anti-muscle kinase receptor-positive myasthenia gravis despite 60-pound weight gain.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014, Jul-15, Volume: 10, Issue:7

Obstructive sleep apnea (OSA) in patients with myasthenia gravis (MG) may be caused by reduced pharyngeal dilator muscle activity. We report a patient with anti-muscle kinase receptor MG with severe OSA and hypoventilation that resolved upon successful treatment of MG despite a 60-lb weight gain.

Topics: Anti-Inflammatory Agents; Female; Follow-Up Studies; Humans; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Prednisone; Sleep Apnea, Obstructive; Treatment Outcome; Weight Gain

2014